Manulife (Manufacturers Life Insurance)
BIOR

Manulife (Manufacturers Life Insurance)’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-54
Closed -$20K – 3193
2021
Q3 		$20K Buy
+54
New +$23.2K ﹤0.01% 3131

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BIOR Position: Q4 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2021, closing a stake of 54 shares — an estimated $20K sold.

Manulife (Manufacturers Life Insurance) first reported a position in BIOR in Q3 2021 and held it in 1 quarter. The position peaked at $20K in Q3 2021. 53 funds tracked by Wall St. Rank hold BIOR as of Q4 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 54 Biora Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $20K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s Biora Therapeutics, Inc. Common Stock position peaked at $20K in Q3 2021.
  • 53 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2021, filed 16 Feb 2022.